Olivier Danos

Biography

Olivier Danos, PhD, is co-founder of Lysogene.  Dr. Danos is currently  Chief Scientific Officer at Regenxbio Inc. (New York, USA). He has over 30 years' of experience in the field of gene therapy as an academic research scientist and as a leader in the biopharmaceutical industry. Prior to joining Regenxbio, Dr. Danos was Senior Vice President of Cell and Gene Therapy at Biogen (Cambridge, USA).  Dr Danos also served as Senior Vice President of Molecular Medicine, Synthetic Biology and Gene Regulation at Kadmon Pharmaceuticals (New York USA). In this role, he was instrumental in assembling a gene therapy program and a technology platform for the development of controlable gene expression systems. Dr. Danos has also been Director of the Gene Therapy Consortium of the University College of London and has led gene therapy research teams at Necker Hospital – Enfants Malades and at the Pasteur Institute in Paris. Dr. Danos also served as Chief Scientific Officer at Genethon and Senior Director of Research at Somatix Therapy Corporation. He is Director of Research (DR1) at the Centre National de la Recherche Scientifique (CNRS). He is a former President and a founding member of the European Society of Gene and Cell Therapy. Dr. Danos received his Master in Genetics and Molecular Biology from the University of Paris Orsay, and his Ph.D. in Biology from the Pasteur Institute and the University of Paris-Diderot.

Research Interest

Bioinformatics & Systems Biology